Medpace Holdings Inc
Închisă
SectorSănătate
458.38 0.52
Rezumat
Modificarea prețului
24h
Minim
455.98
Maxim
460.92
Venit | -11M 124M |
|---|---|
Vânzări | -1.8M 707M |
P/E Medie Sector | 29.031 49.712 |
EPS | 4.28 |
Marjă de profit | 17.53 |
Angajați | 6,300 |
EBITDA | -9.5M 154M |
Recomandări | Cumpărare |
|---|---|
Prognoză pe 12 luni | -1.73% downside |
Următoarele câștiguri | 22 iul. 2026 |
|---|
Capitalizare de piață | -1.9B 13B |
|---|---|
Deschiderea anterioară | 457.86 |
Închiderea anterioară | 458.38 |
Sentimentul știrilor
By Acuity
26%
74%
54 / 342 Clasament în Healthcare
Medpace Holdings Inc Grafic
Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.
Despre Medpace Holdings Inc
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.